skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycododecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(3-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

مفهوم‌های اخص

بار

  • -3

فرمول

  • C119H190N9O87R2

بخشی دارد

جرم

  • 3138.795

جرم تک‌ایزوتوپی

  • 3137.07199

اسمایلٓ

  • O(C[C@@H]([C@@H](*)O)NC(=O)*)[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O[C@]7(O[C@]([C@@H]([C@H](C7)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O)O)NC(=O)C)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@H]([C@H]([C@H](O9)CO[C@H]%10[C@@H]([C@H]([C@@H]([C@H](O%10)CO)O[C@H]%11[C@@H]([C@H]([C@H]([C@H](O%11)CO)O)O[C@]%12(O[C@]([C@@H]([C@H](C%12)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O)O)NC(=O)C)O)O[C@H]%13[C@@H]([C@H]([C@@H]([C@H](O%13)CO)O[C@H]%14[C@@H]([C@H]([C@H]([C@H](O%14)CO)O)O[C@]%15(O[C@]([C@@H]([C@H](C%15)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O)O)NC(=O)C)O)O)NC(=O)C)O)O)NC(=O)C)O)O)O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuNAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-NeuNAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-NeuNAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(3-)
  • a neolactoside VIII(3)-alpha-NeuAc,VI(6),IV(6)-beta-[NeuAc-alpha-(2->3)-Gal-beta-(1->4)-GlcNAc]2-nLc8Cer
  • neolactoside G-12(3-)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:145522

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD